Search

Your search keyword '"Bonadona, V."' showing total 232 results

Search Constraints

Start Over You searched for: Author "Bonadona, V." Remove constraint Author: "Bonadona, V."
232 results on '"Bonadona, V."'

Search Results

51. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

52. Familial hematological malignancies: ASXL1 gene investigation

53. Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

54. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

55. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

56. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

59. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

60. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

61. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

62. Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

63. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

64. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

65. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

66. Molecular study of the perforin gene in familial hematological malignancies

67. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

68. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

69. Étude GENESIS : trois ans d’inclusion en France

73. Oncogénétique: estimation des besoins de la population en France pour les dix ans à venir

74. Estimation du risque de cancer du sein dans une cohorte prospective de femmes porteuses d’une mutation sur les gènes BRCA : cohorte nationale GENEPSO

80. P17-7 Impact d’un livret d’information sur les connaissances, la satisfaction et la décision de demander un test génétique

81. P2-3 Analyse des facteurs histologiques prédictifs d’une mutation germinale de BRCA1/2 dans le cancer du sein précoce, à partir d’une étude en population

86. Endometrial carcinoma (EC) in women with breast cancer (BC)

88. Patients' characteristics and rate of Internet use to obtain cancer information.

89. BRAF as a melanoma susceptibility candidate gene?

90. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result

91. Pathway-Based Analysis of a Melanoma Genome-Wide Association Study: Analysis of Genes Related to Tumour-Immunosuppression

92. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

93. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

94. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

95. Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors.

96. Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age window.

97. An Integrated Cancer Prevention Strategy: the Viewpoint of the Leon Berard Comprehensive Cancer Center Lyon, France.

98. Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort.

99. Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.

100. First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants.

Catalog

Books, media, physical & digital resources